SEGMENTS - Summarized Financial Information by Segment (Details) - USD ($) $ in Thousands			3 Months Ended
		Apr. 01, 2019	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues			$ 114,802	$ 81,875
Cost of product revenue			53,705	42,767
Research and development		$ 300	826	450
Plasma center operating expenses			1,286	1,005
Depreciation and amortization expense			1,969	2,114
Consolidated selling, general and administrative expense			24,079	15,639
Other expense, net			(1,431)	(3,420)
Income (loss) before taxes			33,450	18,401
Unallocated interest expense, primarily related to interest on senior debt (see Note 6)			1,975	3,769
Unallocated interest income			608	384
Total assets			510,569	350,875	$ 488,678
Operating Segments [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues			114,766	81,839
Cost of product revenue			53,705	42,767
Research and development			826	451
Plasma center operating expenses			1,286	1,005
Selling, marketing and distribution			6,044	4,431
Depreciation and amortization expense			25	193
General and administrative expense			8,495	5,351
Other expense, net			(64)	(31)
Income (loss) before taxes			44,321	27,610
Expenditures for additions to long-lived assets			4,720	2,347
Total assets			357,735	312,321
Reconciling Item [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues			36	36
Income (loss) before taxes			36	36
Unallocated interest expense, primarily related to interest on senior debt (see Note 6)			(1,975)	(3,769)
Unallocated interest income			608	381
Corporate [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
General and administrative expense	[1]		9,540	5,857
Income (loss) before taxes	[1]		(9,540)	(5,857)
Total assets	[2]		152,834	38,554
ADMA BioManufacturing [Member] | Operating Segments [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues			113,716	80,113
Cost of product revenue			53,057	40,991
Research and development			826	451
Plasma center operating expenses			0	0
Selling, marketing and distribution			6,044	4,431
Depreciation and amortization expense			25	193
General and administrative expense			8,495	5,351
Other expense, net			(64)	(30)
Income (loss) before taxes			45,205	28,666
Expenditures for additions to long-lived assets			4,699	2,330
Total assets			330,091	278,331
Plasma Collection Centers [Member] | Operating Segments [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues			1,050	1,726
Cost of product revenue			648	1,776
Research and development			0	0
Plasma center operating expenses			1,286	1,005
Selling, marketing and distribution			0	0
Depreciation and amortization expense			0	0
General and administrative expense			0	0
Other expense, net			0	(1)
Income (loss) before taxes			(884)	(1,056)
Expenditures for additions to long-lived assets			21	17
Total assets			$ 27,644	$ 33,990

[1] Primarily includes compensation expense, including stock-based compensation expense, for certain executive officers and consultants, insurance, legal and investor relations expenses and accounting and tax fees that are not allocated to the Company's operating segments.

[2] Primarily consists of cash and deferred tax assets.